baber/WOPTO huggingface dataset:
Patent NZ-230254-A (NZ)
Title: Dual source parenteral infusion system: includes secondary infusion module
Inventor: EGGERS PHILIP N
IPC: A61M5/14
Filed: 1989-08-08
Abstract: A dual source parenteral infusion system includes a primary controller (20) which controls the flow rate of a parenteral solution, a display (28) which displays parameters associated with the delivery of a primary solution (2), and pushbuttons (30) for entering solution delivery parameters into the controller (20). The primary controller (20) communicates with a secondary infusion module (40) which is programmed to deliver solution from a secondary source (24), with the flow rate being controlled by the primary controller (20). The secondary infusion module (40) includes a display (42) for displaying parameters associated with the delivery of the secondary solution (24) and a drop detector, and mounts about a drip chamber for the secondary solution (24). The module (40) may also include pushbuttons (44) for entering fluid delivery parameters for the secondary solution (24) into the module (40).
Patent NZ-231402-A (NZ)
Title: Device for screening pulp suspensions including cylindrical screening member
Inventor: LUNDBERG JORGEN
IPC: D21D5/02
Filed: 1989-11-15
Abstract: PCT No. PCT/SE89/00568 Sec. 371 Date Mar. 21, 1991 Sec. 102(e) Date Mar. 21, 1991 PCT Filed Oct. 16, 1989 PCT Pub. No. WO90/05807 PCT Pub. Date May 31, 1990.Devices for screening pulp suspensions are disclosed including a cylindrical screen extending longitudinally within a housing, an inlet for feeding the pulp suspension into the interior of the cylindrical screen, an accept outlet for removing the accept portion of the pulp suspension after it has passed through the cylindrical screen, a reject outlet for removing a reject portion of the pulp suspension at the opposite end of the cylindrical screen with respect to the inlet, and a rotor concentrically positioned for rotation within the cylindrical screen such that an annular screen chamber is created between the rotor and the screen, the rotor including wings extending from its exterior such that the wings have a length circumferentially with respect to the rotor which ranges from about 2:1 to about 6:1 with respect to the distance between the rotor and the screen, and the leading edges of the wings being separated a greater distance from the rotor than the trailing edges of the wings.
Patent NZ-231753-A (NZ)
Title: Substituted acyloxypropanolamine derivatives and pharmaceutical compositions
Inventor: PATIL GHANSHYAM
IPC: A61K31/22
Filed: 1989-12-13
Abstract: Compounds of the present invention, are represented by the general formula <CHEM> wherein R represents a straight or branched loweralkyl from 1 to about 6 carbon atoms, loweralkene from 2 to about 6 carbon atoms, or <CHEM> where m is o or 1 and n is 2, 3, 4 or 5 provided that when m is o, n is 2, 3, 4, or 5 and when m is 1, n is 3 or 4, and R1 is hydrogen, a straight, branched or cyclic loweralkyl from 1 to about 6 carbon atoms or loweralkoxy, phenyl or substituted phenyl, and R2 represents a straight or branched loweralkyl from 1 to about 6 carbon atoms or W-B wherein W represents alkylene of from 1 to about 10 carbon atoms which may be substituted with loweralkyl of from 1 to about 4 carbon atoms; and B represents hydrogen, -NHCOR4, or -NHCONR3R4, wherein R3 and R4 may be the same or different and may be hydrogen, alkyl, alkoxyalkyl, cycloalkyl, alkenyl, alkynyl, phenyl or aralkyl wherein the alkyl group contains from 1 to about 6 carbon atoms and the aryl group represents phenyl which may be unsubstituted or substituted with lower alkyl from 1 to about 6 carbon atoms, alkoxy wherein the alkyl group contains from 1 to about 6 carbon atoms, halogen, acetamido, amino, hydroxy, hydroxyalkyl of from 1 to about 10 carbon atoms; thiophenyl, imidazole, oxazole or indole, furanyl, tetrahydrofuranyl or R3 and R4 may together with N form a pyrrolidino, piperidino, piperazino, or morpholino ring, or a pharmaceutically acceptable salt thereof. The compounds are useful in the treatment or prophylaxis of cardiac disorder or in the treatment of glaucoma.
Patent NZ-238956-A (NZ)
Title: 3-arylindole or 3-arylindazole derivatives and medicaments thereof.
Inventor: PERREGAARD JENS KRISTIAN
IPC: A61K31/495
Filed: 1991-07-12
Abstract: 3-Arylindole or 3-arylindazole derivatives having formula: <CHEM> wherein Ar is optionally substituted phenyl or a heteroaromatic group; R<1>-R<4> are independently selected from hydrogen, halogen, alkyl, alkoxy, hydroxy, nitro, alkylthio, alkylsulphonyl, alkyl- or dialkylamino, cyano, trifluoromethyl, or trifluoromethylthio;  the dotted lines designate optional bonds; X is N or a group CR<6> wherein R<6> is hydrogen, halogen, trifluoromethyl or alkyl, or X is CH2; Y is N or CH, or Y is C ; R<5> is hydrogen, cycloalkyl, cycloalkylmethyl, alkyl or alkenyl, optionally substituted with one or two hydroxy groups, or R<5> is a group taken from structures 1a and 1b : <CHEM> wherein n is an integer from 2 - 6; W is O or S; U is N or CH ; Z is -(CH2)m-, m being 2 or 3, -CH=CH- , 1,2-phenylene or -COCH2- or -CSCH2-; V is O, S, CH2, or NR<7>; U<1> is O, S, CH2 or NR<8>; and V<1> is NR<9>R<1><0>, OR<1><1>, SR<1><2> or CR<1><3>R<1><4>R<1><5>, and R<7>-R<1><5> are independently hydrogen, alkyl, alkenyl, cycloalkyl or cycloalkylalkyl ; may be prepared by methods known per se. The compounds are selective centrally acting 5-HT2-antagonists in the brain and are useful in treatment of anxiety, agression, depression, sleep disturbances, migraine, negative symptoms of schizophrenia, drug-induces Parkinsonism and Parkinson's disease.
Patent NZ-256549-A (NZ)
Title: Ink compositions incorporating a water reducible resin whose water solubility is ph dependent; making, using and recovering such compositions
Inventor: PENNAZ THOMAS J
IPC: C09D7/00
Filed: 1993-09-15
Abstract: An ink composition incorporating a water reducible resin which is water insoluble under certain conditions and selectively water washable under certain other conditions. The method aspect of the present invention relates to a method of making, using and recovering the ink composition.
Patent NZ-261252-A (NZ)
Title: Reduced waiting time drilling jar: piston has bypass passage with constant flow valve and pressure relief valve
Inventor: EVANS ROBERT W
IPC: F16F9/516
Filed: 1994-01-05
Abstract: A reduce waiting time drilling jar 1 includes a mandrel 2, a housing 3 telescopingly positioned about the mandrel 2, and first and second pistons 89, 111 positioned axially between the mandrel 2 and the housing 3. The pistons 89, 111 are spaced longitudinally apart, forming a substantially sealed chamber 88 therebetween. The first piston 89 has a first and second substantially parallel flow passage 94, 200 formed therein and extending longitudinally therethrough to provide first and second flow characteristics. A valve 204 is hydraulically connected to the second flow passage 200. The valve 204 is translatable between first and second operating positions, wherein fluid flows relatively freely through the second flow passage 200 in the first operating position, but is restricted in the second operating position. A pressure relief valve 206 is hydraulically coupled to the substantially sealed chamber 88, and mechanically coupled to the valve 204, wherein movement of the pressure relief valve 206 biases the valve 204 between its first and second operating positions in response to the pressure in the chamber 88 rising above a preselected value.
Patent NZ-272401-A (NZ)
Title: Peptides from boronic acid; compounds, their preparation and pharmaceutical compositions containing them
Inventor: DE NANTEUIL GUILLAUME
IPC: C07K5/065
Filed: 1995-06-21
Abstract: Boronic acid peptide derivs. of formula (I) R1NH-C(R2)(R2')-CO-A-CO-NH-CH(R3)-B(OR4)(OR5) and their enantiomers, diastereomers and epimers and their addn. salts are new. In (I), R1 is e.g. H, 1-6C acyl, 2-7C alkoxycarbonyl, benzyloxycarbonyl, etc.; R2 is e.g. H, Ph, thienylmethyl, (pyridinyl) methyl, diphenylmethyl, fluoroenyl, naphthylmethyl etc.; R2' is H or benzyl; or R2+R2' is CHPh; R3 is e.g. (CH2)mSC(=NH)NHR, (CH2)mN(R)CH=NH or gp. of formula (a) etc.; m =1-6; R is H or 1-6C alkyl; X is S or amino; R4 and R5 are H or 1-6C alkyl; or B(OR4)(OR5) is pinanediol boronic ester; A is N(A2)(CH2)n; n = 1-2; A2 is e.g. Ph, indanyl, 3-7C cycloalkyl (opt. ring substd. by 1-6C alkyl), 3-7C cycloalkenyl, bicyclo(2.1.1)hexyl etc..
Patent NZ-300850-A (NZ)
Title: Use of aromatic aldehydes as pesticides
Inventor: EMERSON RALPH W
IPC: A01N35/02
Filed: 1995-12-29
Abstract: ethods and compositions based upon natural flavonoid aldehydes, including cinnamic aldehyde, a-hexyl cinnamic aldehyde, and coniferyl aldehyde are provided, which find use as pesticides.  The compositions are effective against pathogenic fungi, arachnids and insects at concentrations which are not phytotoxic to the treated host plant.  Infestations of a variety of plant parts can be treated, including those of leaves, seeds, seedlings, fruit, flowers and roots.  Susceptible organisms include rust, powdery mildew, botrytis, phylloxera, aphids, thrips, codling moth, nematodes and leaf hoppers.
Patent NZ-331444-A (NZ)
Title: Composition containing clopidogrel and aspirin
Inventor: BERNAT ANDRE
IPC: A61K31/00
Filed: 1997-02-17
Abstract: Described is a synergistic composition of clopidogrel and aspirin.  The composition is used to treat pathologies induced by platelet aggregation such as angina and cardiovascular and cerebrovascular disorders.
Patent NZ-335665-A (NZ)
Title: Applying graphics to paths or roads, graphics laminate applied over moisture barrier
Inventor: BAKER JONINE ANNE
IPC: E01C23/18
Filed: 1999-05-06
Abstract: raphic material is applied to a surface by first applying a moisture barrier to the surface , the barrier also functioning to level surface irregularities.  A graphics laminate 10 is then bonded to the moisture barrier.  The laminate consists of printed material on a substrate such as vinyl film 12, and a protective over laminate 20.  A clear protective layer is then applied to at least seal the edges of the graphics laminate.  The surface may be a road or a path, and the moisture barrier may be a polyurethane and/or epoxy product.
Patent NZ-336850-A (NZ)
Title: Microminiaturized minimally invasive intravascular micro-mechanical systems powered and controlled via fiber-optic cable
Inventor: FITCH JOSEPH P
IPC: A61B19/00
Filed: 1998-03-02
Abstract: The specification describes a micro-mechanical system for medical procedures.  The system  is constructed in the basic form of a catheter (103) having a distal end for insertion into and manipulation within a body and a near end enabling a user to control the manipulation of the distal end within the body. A fiber optics cable is disposed within the catheter.  The cable has a distal end proximate to the distal end of the catheter, and a near end for external coupling of laser light energy. A micro-gripper (70) is attached to the distal end of the catheter providing for the gripping or releasing of an object within the body. A laser light to mechanical power converter is connected to receive laser light from the distal end of the fiber optics cable, and connected to mechanically actuate the micro-gripper.
Patent NZ-502147-A (NZ)
Title: Flow inducer fish guide and method of using same
Inventor: TRUEBE JONATHAN PAUL
IPC: A01K61/00
Filed: 1998-06-09
Abstract: An apparatus is disclosed for generating a current to guide fish includes a propeller (10), a device (12) to rotate the propeller, and a frame (14) to mount the propeller and the device to rotate the propeller. Fish may be guided from an intake area to a fish bypass (22) by generating a current leading away from the intake area. The apparatus may also be used to guide fish through low velocity areas in river situations.
Patent NZ-503984-A (NZ)
Title: Viral encoded semaphorin protein receptor (VESPR) DNA and polypeptides to treat inflammatory conditions
Inventor: SPRIGGS MELANIE KAY
IPC: C07K14/705
Filed: 1998-10-28
Abstract: Described are VESPR polypeptides as a purified and isolated protein, the DNA encoding the VESPR polypeptide, host cells transfected with cDNAs encoding VESPR, and methods for preparing VESPR polypeptides.
Patent NZ-505439-A (NZ)
Title: Therapeutic and diagnostic methods dependent on CYP2A enzymes
Inventor: SELLERS EDWARD M
IPC: A61K31/37
Filed: 1998-12-01
Abstract: A method for enhancing the effectiveness of a nicotine replacement therapy comprising administering to an individual in need (a) nicotine and (b) one or more substances selected from the group consisting of (i) substances which inhibit CYP2A activity; (ii) substances which inhibit transcription, translation of the gene encoding CYP2A, or both; (iii) substances which delete all or a portion of the gene encoding CYP2A; wherein the substances may be selected from methoxsalen, psoralen, tranylcypromine, pilocarpine, coumarin, chromone, esculetin, phenelzine, paroxetine, selegiline and pargyline.
Patent NZ-511209-A (NZ)
Title: Improvements in and relating to drug delivery apparatus
Inventor: DYCHE ANTHONY
IPC: A61B5/087
Filed: 1999-10-26
Abstract: A nebuliser having elements for determining the duration of a pulse of atomisation during inspiration, including elements for measuring the tidal volume of a patient timing elements for measuring the duration of inspiration, elements for storing estimates of the volume of a patient's upper airway, and elements for calculating the duration of the pulse. The duration of the pulse is calculated on the basis of the tidal volume measured by the tidal volume measuring elements; the duration of inspiration measured by the timing elements, and the stored estimated volume of patient's upper airway from the storage elements
Patent NZ-514348-A (NZ)
Title: L-ribo-LNA analogues
Inventor: WENGEL JESPER
IPC: C12Q1/68
Filed: 2000-05-04
Abstract: Described is an oligomer comprising at least one nucleoside analogue of formula Ia, wherein: X is selected from -O- and -S-, P is the radical position for an internucleoside linkage to a succeeding monomer, or a 5'-terminal group, the internucleoside linkage or 5'-terminal group optionally substituted. P* designates an internucleoside linkage to a preceding monomer or 3'-terminal group. The oligomer is used in the manufacture of a medicament for the diagnosis or treatment of viral infection or cancer.
Patent NZ-519347-A (NZ)
Title: A method to produce cloned embryos and adults from cultured cells particulary from embryonic stem (ES) cell lines
Inventor: PERRY ANTHONY C F
IPC: A01K67/027
Filed: 2000-12-20
Abstract: A method for cloning a non-human embryo comprises the steps of (a) collecting the nucleus of a cultured non-human embryonic stem or embryonic germ cell, (b) microinjecting the nucleus of (a) or at least a portion of thereof that includes the chromosomes into an enucleated oocytes to reconstitute the cell and (c) allowing the reconstituted cell to develop embryonically. Also described are methods for clonally deriving differentiated non-humans cells and modulating non- human embryonic development.
Patent NZ-521864-A (NZ)
Title: Sign cartridge
Inventor: SACHA JORDAN
IPC: G09F13/04
Filed: 2001-03-30
Abstract: An internally illuminated sign carrying element of an emergency light and sign assembly is provided, in which a base unit (11) is arranged to be mounted to a ceiling (33) and the sign body (12) clips onto the base. The sign carrier element (12) extends below the base unit (11) and is removable from the base unit (11). Electrical connection between the removable sign carrier (12) and the electronic module (16) of the base unit (11) is via a pair of cooperating electrical connectors (24, 25). The sign element (12) is formed in a transparent, semi-transparent or translucent material and is moulded as a pair of shell halves which when assembled together, encapsulate two light sources (26, 27), an upper one of which (light source 26) performs a normal sign illuminating function and the other of the two light sources (27), performs an emergency illumination function whereby the sign is illuminated, as well as a surrounding area of the floor under emergency conditions. The base unit (11), houses batteries (14), transformers (15) and an electronics module (16) carrying the communications control, battery charging, device monitoring and electronic ballast circuits required to perform emergency lighting and illuminated sign functions.
Patent NZ-522809-A (NZ)
Title: Wireless radio data protective device for private/public network wireless packet data services and authentication method according to internet connection request of mobile terminals receiving the services
Inventor: LEE GUI-JUNG
IPC: H04W12/00
Filed: 2002-11-26
Abstract: A wireless data protective device in a communication system for providing private/public network wireless packet data services includes: intranet connected to the Internet through a firewall system; and private base station controller, mounted with a packet data processor for doing wireless data communication with a mobile terminal through private or public base station, and for enabling the terminal to exchange packet data through the intranet. In addition, an authentication method at a request of the mobile terminal for Internet connection in the communication system, mounted with the wireless data protective device, for providing private/public network wireless packet data services.
Patent NZ-526702-A (NZ)
Title: Raising mechanism for a venetian blind
Inventor: YEOW CHAN TIM
IPC: E06B9/32
Filed: 2003-06-26
Abstract: A venetian blind (50) having a top bar (21), a bottom bar (20), horizontal slats (35) disposed between the top and bottom bars (21; 20), a raising mechanism (30, 31) for adjusting the height of the bottom bar (20) of the venetian blind (5) is disclosed, wherein the raising mechanism (30, 31) comprises: a first member (11, 13) attached to the top bar (21); a second member (10, 12) attached to the bottom bar (20); and a cord (1, 2), which is attached at one end to the venetian blind (50) and is past the first and second members (11, 13; 10, 12), wherein displacement of the free end of the cord (25) is greater than the displacement of the bottom bar (20) with a mechanical advantage.
Patent NZ-526743-A (NZ)
Title: Interleukin-18 inducing agent
Inventor: HAYASAWA HIROTOSHI
IPC: C12P21/06
Filed: 2002-10-29
Abstract: An interleukin-18 inducer comprising a whey protein hydrolysate which is obtained by hydrolysing whey proteins with hydrolase and which has a function to induce interleukin-18, as an active ingredient.
Patent NZ-528287-A (NZ)
Title: Novel fungicide compositions based on propamocarb and pyridylmethylbenzamide derivative
Inventor: EMERY JANE CATHERINE
IPC: A01N43/40
Filed: 2002-02-19
Abstract: Disclosed herein are fungicide compositions comprising: (a) at least a pyridylmethylbenzamide derivative of formula (I) wherein the various radicals are as defined in the specification and (b) at least a compound (II) which is propamocarb. Curative or preventive method for fighting against phytopathogenic fungi of crops are also disclosed, wherein the method consists applying an efficient and non-phytotoxic amount of the fungicide compositions on the aerial parts of plants.
Patent NZ-531576-A (NZ)
Title: Cross-linked glycopeptide-cephalosporin antibiotics
Inventor: FATHEREE PAUL
IPC: C07K9/00
Filed: 2002-10-11
Abstract: Cross-linked glycopeptide cephalosporin compounds of formula (I) and pharmaceutically acceptable salts thereof which are useful as antibiotics are disclosed, wherein the variables shown in formula (I) are as defined in the specification. Processes and intermediates useful for preparing these compounds and pharmaceutical compositions containing these compounds are also disclosed. These compounds are suitable for treating bacterial infections in a mammal.
Patent NZ-532450-A (NZ)
Title: System and method for approximating half duplex wireless dispatch system
Inventor: MAGGENTI MARK
IPC: H04B7/26
Filed: 2002-10-23
Abstract: The method disclosed provides a dispatch service to plural users of mobile stations in a full duplex wireless dispatch network. The network includes at least one base station (BTS), at least one talking mobile station (MS), at least one listening MS, and respective link pairs. Each link pair includes a forward link and a reverse link between the BTS and at least one MS. The method comprises: permitting the talking MS to transmit voice information in a dispatch service over the reverse link associated with the talking MS; providing the voice information to the listening MS over the forward link associated with the listening MS; and reducing or eliminating energy transmission in at least one of: the reverse link associated with the listening MS, and the forward link associated with the talking MS. The reducing or eliminating act includes reducing at least one duty cycle.
Patent NZ-534122-A (NZ)
Title: Dihydro-benzo[b][1, 4]diazepin-2-one derivatives for the treatment of neurological disorders
Inventor: ADAM GEO
IPC: A61P25/18
Filed: 2003-01-28
Abstract: Dihydro-benzo [b] [1,4] diazepin-2-one derivatives of formula (I) are disclosed, wherein R1, R2, X and Y are as defined in the specification and R3 is a six-membered aromatic heterocycle containing 1 to 3 nitrogen atoms or a pyridine-N-oxide as further defined in the specification. Also disclosed are medicaments containing these compounds, a process for their preparation as well as their use for preparation of medicaments for the treatment or prevention of acute and/or chronic neurological disorders including psychosis, schizophrenia, Alzheimer's disease, cognitive disorders and memory deficits.
Patent NZ-535685-A (NZ)
Title: Preparation of 2-(7-chloro-1,8-napthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isindolinone, or pagoclone - a GABA receptor ligand
Inventor: STUK TIMOTHY LEE
IPC: C07D413/14
Filed: 2003-03-17
Abstract: A method of making racemic 2-(7-chloro-1,8-naphthyridin-2-yI)-3-(5- methyl-2-oxohexyl)-1-isoindolinone is disclosed, the method comprises the step of reacting hydroxyindolinone of formula (4) with a 5-methyl-2-oxo-hexyl triphenylphosphonium halide to form racemic 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-1-isoindolinone which may be further resolved to provide (+)-2-(7-chloro-1,8-naphthyridin-2-yI)-3-(5- methyl-2-oxohexyl)-1-isoindolinone.
Patent NZ-536164-A (NZ)
Title: A door furniture mounting apparatus including a handle with at least one rosette
Inventor: LAMBROU HARRY
Filed: 2004-10-27
Abstract: A door furniture mounting apparatus 10 for mounting a door 28 having first and second opposed surfaces. The apparatus comprises a handle 12 having at least one rosette 14. The rosette(s) 14 have a substantially central threaded hole 16, an offset threaded hole 18a and an offset plain hole 18b. To secure one of the rosettes 14 to the door first surface, a threaded fastener 20 is inserted from the door second surface, into engagement with the central threaded hole 16. Two secure two rosettes 14 on the opposed surfaces of the door, each rosette 14 is arranged with the offset plain hole 18b coaxial with the offset threaded hole 18a of the other rosette 14, and a threaded fastener 38a, 38b is inserted through each offset plain hole 18b into engagement with each offset threaded hole 18a.
Patent NZ-538542-A (NZ)
Title: Compounds to treat Alzheimer's disease
Inventor: MAILLARD MICHAEL
IPC: C07C243/28
Filed: 2001-06-29
Abstract: Disclosed are protected compounds of formula (III) and (IV) wherein: R1 is -(CH2)-phenyl optionally substituted by one, two, three or four substituents as defined; R2 and R3 are hydrogen; X1 is -Cl, -Br, -I, or -OSO2Rx, where Rx is 4-methylphenyl-, 3-nitrophenyl, or CH3-; and The protecting group is as defined. Compounds of the type disclosed are useful as intermediates in the manufacture of a medicament for treating Alzheimer's disease, in particular for inhibiting beta-secretase-mediated cleavage of amyloid precursor protein (APP).